| Product Code: ETC13149205 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Neuropathic Pain Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Neuropathic Pain Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 North America Neuropathic Pain Market - Industry Life Cycle |
3.4 North America Neuropathic Pain Market - Porter's Five Forces |
3.5 North America Neuropathic Pain Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 North America Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.9 North America Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 North America Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.11 North America Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.12 North America Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
3.12 North America Neuropathic Pain Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 North America Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Neuropathic Pain Market Trends |
6 North America Neuropathic Pain Market, 2021 - 2031 |
6.1 North America Neuropathic Pain Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Neuropathic Pain Market, Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021 - 2031 |
6.1.3 North America Neuropathic Pain Market, Revenues & Volume, By External Peripheral Nerve Stimulation, 2021 - 2031 |
6.1.4 North America Neuropathic Pain Market, Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021 - 2031 |
6.2 North America Neuropathic Pain Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Neuropathic Pain Market, Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021 - 2031 |
6.3 North America Neuropathic Pain Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Neuropathic Pain Market, Revenues & Volume, By Invasive and Non-Invasive, 2021 - 2031 |
6.4 North America Neuropathic Pain Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Neuropathic Pain Market, Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021 - 2031 |
6.4.3 North America Neuropathic Pain Market, Revenues & Volume, By Transcranial Magnetic Stimulation, 2021 - 2031 |
6.4.4 North America Neuropathic Pain Market, Revenues & Volume, By Respiratory Electrical Stimulation, 2021 - 2031 |
6.5 North America Neuropathic Pain Market, Revenues & Volume, By Modality, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Neuropathic Pain Market, Revenues & Volume, By Stationary, 2021 - 2031 |
6.5.3 North America Neuropathic Pain Market, Revenues & Volume, By Portable, 2021 - 2031 |
6.6 North America Neuropathic Pain Market, Revenues & Volume, By Mode of Purchase, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Neuropathic Pain Market, Revenues & Volume, By Over-the-Counter Devices, 2021 - 2031 |
6.6.3 North America Neuropathic Pain Market, Revenues & Volume, By Prescription-Based Devices, 2021 - 2031 |
6.7 North America Neuropathic Pain Market, Revenues & Volume, By Pain Type, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 North America Neuropathic Pain Market, Revenues & Volume, By Peripheral Neuropathy, 2021 - 2031 |
6.7.3 North America Neuropathic Pain Market, Revenues & Volume, By Entrapment Neuropathy, 2021 - 2031 |
6.7.4 North America Neuropathic Pain Market, Revenues & Volume, By Phantom Limb Neuropathy, 2021 - 2031 |
6.7.5 North America Neuropathic Pain Market, Revenues & Volume, By Trigeminal Neuralgia, 2021 - 2031 |
6.7.6 North America Neuropathic Pain Market, Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021 - 2031 |
6.7.7 North America Neuropathic Pain Market, Revenues & Volume, By Post Traumatic Neuropathy, 2021 - 2031 |
6.7.8 North America Neuropathic Pain Market, Revenues & Volume, By Foot Pain, 2021 - 2031 |
6.7.9 North America Neuropathic Pain Market, Revenues & Volume, By Coccydynia, 2021 - 2031 |
6.8 North America Neuropathic Pain Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 North America Neuropathic Pain Market, Revenues & Volume, By Spinal Stenosis, 2021 - 2031 |
6.8.3 North America Neuropathic Pain Market, Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021 - 2031 |
6.8.4 North America Neuropathic Pain Market, Revenues & Volume, By Diabetic Neuropathy, 2021 - 2031 |
6.8.5 North America Neuropathic Pain Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Neuropathic Pain Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Neuropathic Pain Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Neuropathic Pain Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
7.3.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.2 Canada Neuropathic Pain Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Neuropathic Pain Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.4.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.4.2 Canada Neuropathic Pain Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.4.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.5 North America Neuropathic Pain Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.2 Canada Neuropathic Pain Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6 North America Neuropathic Pain Market, Revenues & Volume, By Modality, 2021 - 2031 |
7.6.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Modality, 2021 - 2031 |
7.6.2 Canada Neuropathic Pain Market, Revenues & Volume, By Modality, 2021 - 2031 |
7.6.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Modality, 2021 - 2031 |
7.7 North America Neuropathic Pain Market, Revenues & Volume, By Mode of Purchase, 2021 - 2031 |
7.7.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Mode of Purchase, 2021 - 2031 |
7.7.2 Canada Neuropathic Pain Market, Revenues & Volume, By Mode of Purchase, 2021 - 2031 |
7.7.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Mode of Purchase, 2021 - 2031 |
7.8 North America Neuropathic Pain Market, Revenues & Volume, By Pain Type, 2021 - 2031 |
7.8.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Pain Type, 2021 - 2031 |
7.8.2 Canada Neuropathic Pain Market, Revenues & Volume, By Pain Type, 2021 - 2031 |
7.8.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Pain Type, 2021 - 2031 |
7.9 North America Neuropathic Pain Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.9.1 United States (US) Neuropathic Pain Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.9.2 Canada Neuropathic Pain Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.9.3 Rest of North America Neuropathic Pain Market, Revenues & Volume, By Indication, 2021 - 2031 |
8 North America Neuropathic Pain Market Key Performance Indicators |
9 North America Neuropathic Pain Market - Export/Import By Countries Assessment |
10 North America Neuropathic Pain Market - Opportunity Assessment |
10.1 North America Neuropathic Pain Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.4 North America Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
10.5 North America Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.6 North America Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
10.7 North America Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
10.8 North America Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
10.9 North America Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
11 North America Neuropathic Pain Market - Competitive Landscape |
11.1 North America Neuropathic Pain Market Revenue Share, By Companies, 2022 |
11.2 North America Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |